mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000
View company profile
Please contact the Account Manager for opportunities with this organisation

Covidien and Philips combine their technology

Posted on 15/06/2009 in Medical Company Product News

Covidien has stated its partnership with Philips will give hospitals further access to advanced technology.

The former's Nellcor OxiMax oximetry system has been integrated into the latter's IntelliVue and M-Series patient monitors.

Further flexibility will now be available to medical professionals as result and the devices are expected to be used in departments such as intensive care, anaesthesia and emergency.

Doctors will be able to use the SoftCare non-adhesive sensor line for those who have sensitive skin ? such as newborns ? and if a patient with poor perfusion is being treated, there is the option of the Max-Fast.

General manager and vice-president of Covidien's patient monitoring division Chris Lowery noted medical professionals are under pressure to improve outcomes, while also decreasing costs.

"This collaboration ? is consistent with ? [the company's] mission to provide products that help clinicians deliver safe and efficacious patient care, while simultaneously maximising hospital efficiency," he asserted.

Last month, the healthcare product provider discussed the benefits of its OxiNet III remote respiratory monitoring.

It said the system had been implemented in hundreds of hospitals and was being used for some 10,000 patients.

Other news stories from 15/06/2009

Read more in the Zenopa News Archive

How this news is generated

Ella
Account Manager
for this opportunity

01494 818 013
(Mon to Fri 0830 to 1800 hours)
ella@zenopa.com

Latest News

Covidien approved to use new reactor for medical isotope production

Covidien agrees new deal for medical isotope supply

Covidien reveals financial results for first quarter of 2010

Covidien announces Aspect Medical Systems' acceptance of tender offer

Covidien announces new FDA action review date for Exalgo

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use